Caroline L Smith Selected Research

Vaccinia

12/2005	Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
1/2005	Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caroline L Smith Research Topics

Disease

2	Melanoma (Melanoma, Malignant) 12/2005 - 01/2005
2	Vaccinia 12/2005 - 01/2005
2	Communicable Diseases (Infectious Diseases) 12/2005 - 01/2005
2	Neoplasms (Cancer) 12/2005 - 01/2005
1	Hypoxia (Hypoxemia) 01/2022
1	Obesity 10/2020
1	Smallpox (Variola) 12/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2005
1	Atherosclerosis 10/2005
1	Virus Diseases (Viral Diseases) 01/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

2	HLA-A*02:01 antigenIBA 12/2005 - 01/2005
2	EpitopesIBA 12/2005 - 01/2005
2	VaccinesIBA 12/2005 - 01/2005
1	T-18 (T 18)IBA 01/2022
1	GlucocorticoidsIBA 10/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2005
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2005

Therapy/Procedure

1	Injections 12/2005
1	Therapeutics 10/2005
1	Immunotherapy 01/2002